-
EP4086277
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4086277
| EP4086277 - LONG-ACTING GLP-1 COMPOUND [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 07.10.2022 Database last updated on 19.07.2024 | |
| Former | The international publication has been made Status updated on 10.07.2021 | Most recent event Tooltip | 17.01.2024 | Supplementary search report | published on 14.02.2024 [2024/07] | Applicant(s) | For all designated states Gan & Lee Pharmaceuticals Co., Ltd. No. 8 Nanfeng West 1st Street Huoxian Tongzhou District Beijing 101109 / CN | [2022/45] | Inventor(s) | 01 /
GAN, Zhongru No.8 Nanfeng West 1st Street, Huoxian, Tongzhou District Beijing 101109 / CN | 02 /
CHEN, Wei No.8 Nanfeng West 1st Street, Huoxian, Tongzhou District Beijing 101109 / CN | 03 /
ZHANG, Yining No.8 Nanfeng West 1st Street, Huoxian, Tongzhou District Beijing 101109 / CN | 04 /
XUE, Fangkai No.8 Nanfeng West 1st Street, Huoxian, Tongzhou District Beijing 101109 / CN | 05 /
CAI, Lingyu No.8 Nanfeng West 1st Street, Huoxian, Tongzhou District Beijing 101109 / CN | 06 /
NIU, Jianghong No.8 Nanfeng West 1st Street, Huoxian, Tongzhou District Beijing 101109 / CN | 07 /
MU, Bin No.8 Nanfeng West 1st Street, Huoxian, Tongzhou District Beijing 101109 / CN | [2022/45] | Representative(s) | Kraus & Lederer PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE | [N/P] |
| Former [2022/45] | Ladendorf, Oliver Kraus & Weisert Patentanwälte PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE | Application number, filing date | 20909624.7 | 29.12.2020 | [2022/45] | WO2020CN141057 | Priority number, date | CN201911397405 | 30.12.2019 Original published format: CN201911397405 | CN20201153306 | 29.09.2020 Original published format: CN202011053306 | [2022/45] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021136303 | Date: | 08.07.2021 | Language: | ZH | [2021/27] | Type: | A1 Application with search report | No.: | EP4086277 | Date: | 09.11.2022 | Language: | EN | [2022/45] | Search report(s) | International search report - published on: | CN | 08.07.2021 | (Supplementary) European search report - dispatched on: | EP | 16.01.2024 | Classification | IPC: | C07K14/605, A61K38/26, A61P3/10, A61K9/00, A61K9/08, A61K47/26 | [2024/07] | CPC: |
A61P3/10 (EP,US);
C07K14/605 (EP,KR,US);
A61K38/26 (EP,KR);
A61K38/28 (KR,US);
A61K47/02 (US);
A61K47/10 (US);
A61K47/26 (EP);
A61K9/0019 (EP);
A61K9/08 (EP);
|
| Former IPC [2022/45] | C07K14/605, A61K38/26, A61P3/10 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/45] | Title | German: | LANGWIRKENDE GLP-1-VERBINDUNG | [2022/45] | English: | LONG-ACTING GLP-1 COMPOUND | [2022/45] | French: | COMPOSÉ GLP-1 À ACTION PROLONGÉE | [2022/45] | Entry into regional phase | 23.06.2022 | Translation filed | 23.06.2022 | National basic fee paid | 23.06.2022 | Search fee paid | 23.06.2022 | Designation fee(s) paid | 23.06.2022 | Examination fee paid | Examination procedure | 23.06.2022 | Examination requested [2022/45] | 09.02.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 14.12.2022 | Renewal fee patent year 03 | 13.12.2023 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO2006097537 (NOVO NORDISK AS [DK], et al); | [E]WO2021136293 (GAN & LEE PHARMACEUTICALS [CN]); |